icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Antiviral Characterization of a Next Generation Chemical
Series ofHBV Capsid Inhibitors In Vitro and In Vivo

 
 
  Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
 
Nagraj Mani1, Andrew G. Cole1, Janet R. Phelps1, Cory Abbott1, Andrzej Ardzinski1, Jeff Bechard1, Robbin Burns1, Tim Chiu1, Andrea Cuconati1, Bruce D. Dorsey1, Ellen Evangelista1, Kristi Fan1, Laurel Fu1, Fang Guo1, Haitao Guo2, Troy O. Harasym1, Agnes Jarosz1, Salam Kadhim1, Steven G. Kultgen1,
Kaylyn Kwak1, Amy C.H. Lee1, Alice H. Li1, Sara Majeski1, Kevin McClintock1, Angela Miller1, Chris Pasetka1, Stephen P. Reid1, Rene Rijnbrand1, Alexander Shapiro1, Holly M. Steuer1, Kim Stever1, Sunny Tang1, Xiaowei Teng1, Xiaohe Wang1, Hu Zhang2, Michael J. Sofia1
1Arbutus Biopharma, Burnaby, BC, Canada and Warminster, PA, United States; 2. Indiana University, Indianapolis, IN, United States.

1110171

1110172

1110173

1110174

1110175